For more VICC news, visit their website »
Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies (C2T2), director of the Breast Cancer Research Program and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of Oncology Programs at the UT Southwestern Medical Center in Dallas.
Lisa Kachnic, M.D., Cornelius Vanderbilt Chair in Radiation Oncology and chair of the Department of Radiation Oncology at Vanderbilt University Medical Center (VUMC), has been named one of the “Women to Watch” in health care by Nashville Medical News.
The association between tobacco use and cancer is well known. But there are other risk factors for cancer that are less recognized, including the link between cancer and certain viruses.
Lauren Hackett, MPA, executive director of Administration and chief business officer for Vanderbilt-Ingram Cancer Center (VICC), has been elected to serve on the Finance Committee for the National Comprehensive Cancer Network (NCCN).
A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.